loader from loading.io

Using DNA to Treat Genetic Diseases

Innovation Unleashed Podcast

Release Date: 11/26/2019

Rapid Detection of Infectious Disease  show art Rapid Detection of Infectious Disease

Innovation Unleashed Podcast

With global population on track to reach 10 billion within a few decades, and with travel and trade steadily intensifying across the world, the spread of many types of infectious disease (like the Flu and worse) is a real and increasing threat to global health .

info_outline
Using DNA to Treat Genetic Diseases show art Using DNA to Treat Genetic Diseases

Innovation Unleashed Podcast

Working to treat genetic diseases is complicated, demanding work and requires the commitment and intellectual power of people who are dedicated to finding answers. Today’s guest Scott Sneddon is one of those people. Scott is the President & CEO of Sharp Edge Labs. He is an entrepreneur and scientist trained in chemistry and biology with an emphasis on computational methods.

info_outline
Tummlers Help Create Successful Innovation Communities show art Tummlers Help Create Successful Innovation Communities

Innovation Unleashed Podcast

Our guest on this episode knows all about entrepreneurs helping entrepreneurs. Kit Mueller is known as a Serial Tummler or a person who connects people and makes things happen. And that’s what Kit has been doing in Pittsburgh’s tech sector for years. Kit describes himself as an “Entrepreneurial Community Builder with a proven history of entrepreneurial success in the software and creative industries.

info_outline
Patients First show art Patients First

Innovation Unleashed Podcast

On this episode, we are going to talk with Patrick Colletti the COO and newly named Chief Innovation Officer of Net Health, a company that creates software solutions for specialized outpatient care. Net Health serves healthcare professionals essentially all of the largest hospital chains in the US as well as private practices around the country.

info_outline
Survey Says show art Survey Says

Innovation Unleashed Podcast

Are opinion polls important? What is the science behind them? Are they sophisticated analyses or back of the envelope calculations? Should we trust what they say? Can they be manipulated and misused? John Dick is the CEO of CivicScience. CivicScience provides strategic insight services to decision-makers at the largest brands, media companies, and investment firms in the world.

info_outline
More People. More Big Ideas. show art More People. More Big Ideas.

Innovation Unleashed Podcast

Our guest, Audrey Russo, is an impassioned thought leader about technology and demographics being codependent drivers of the Pittsburgh economy and the success of the technologies that are developed here.

info_outline
The Science of Working in Teams  show art The Science of Working in Teams

Innovation Unleashed Podcast

We are fortunate to be joined on this episode by a renowned expert in the study of teams and collective intelligence. Anita Woolley, is an Associate Professor of Organizational Behavior and Theory at the Tepper School of Business, Carnegie Mellon University. She has a PhD in Organizational Behavior from Harvard University, where she also earned Bachelor’s and Master’s degrees.

info_outline
Reshaping the World with Machine Learning show art Reshaping the World with Machine Learning

Innovation Unleashed Podcast

It is interesting that on this episode, we are joined by John Kitchin, a chemical engineering expert who is using machine learning to develop new tools to change the way that research is being conducted.

info_outline
Saving the World’s Water from Our Own Destruction  show art Saving the World’s Water from Our Own Destruction

Innovation Unleashed Podcast

On this episode, we are joined by two pioneers who are working to use chemistry and technology to safely reduce/eliminate hazardous chemical contaminants and pathogens from water. Dr. Terry Collins is the Teresa Heinz Professor in Green Chemistry, Chemistry and Director, Institute for Green Science at Carnegie Mellon University and Professor Ryan Sullivan, working in both Chemistry and Mechanical Engineering at Carnegie Mellon University.

info_outline
The Making of Schmoopie, Uncle Sam, Betsy Ross, Pepperoni, and Monster Max  show art The Making of Schmoopie, Uncle Sam, Betsy Ross, Pepperoni, and Monster Max

Innovation Unleashed Podcast

On this episode, our guest is a serial entrepreneur and a world-renowned inventor. He has been called a snake charmer……and has famously charmed snakes by the name of schmoopie, Uncle Sam, Betsy Ross, Pepperoni, and Monster Max - - - Mechanical robotic snakes that can explore tight spaces, swim, climb poles…. and solve big problems.

info_outline
 
More Episodes

DNA or deoxyribonucleic acid, is perhaps the most well-known biological molecule. DNA is present in all forms of life on earth. Essentially, every cell in our bodies contains DNA or the genetic instructions - or code - that makes us what we are. DNA has a unique double helix shape, like a twisted ladder and carries these instructions or code for the development, growth, reproduction, functioning and health of all life. Remarkably, if all of the DNA in a human body was unraveled, it would reach to the sun and back more than 300 times.

The code in DNA is determined by the order of the four nucleotide bases that make up DNA, adenine, cytosine, guanine and thymine and is the complete set of genes and is called a genome.

As the National Human Genome Research Institute works to unlock the secrets of the human genome, researchers continue learning that nearly all diseases that we face have a genetic component. Some diseases are caused by mutations that are inherited from parents and are present in an individual at birth, like sickle cell disease, for example. Other diseases are caused by acquired mutations in a gene or group of genes that occur during a person's life. Such mutations are not inherited from a parent, but occur either randomly or due to some environmental exposure like pollutants. Today’s guest is working tirelessly to create therapies to treat genetic diseases. Specifically, Monogenic diseases.

As defined by the World Health Organization, Monogenic diseases result from modifications in a single gene occurring in all cells of the body. Though relatively rare, they affect millions of people worldwide. Researchers estimate that over 10,000 of human diseases are known to be monogenic. Pure genetic diseases are caused by a single error in a single gene in the human DNA.

As you can gather from my brief description, working to treat genetic diseases is complicated, demanding work and requires the commitment and intellectual power of people who are dedicated to finding answers. Today’s guest Scott Sneddon is one of those people. Scott is the President & CEO of Sharp Edge Labs. He is an entrepreneur and scientist trained in chemistry and biology with an emphasis on computational methods. He holds a Ph.D. in Chemistry & Biophysics from Carnegie-Mellon University, a J.D. from Columbia University Law School and has over 20 years of experience in the drug discovery industry, having held leadership positions at Pfizer and Genzyme. At Pfizer Dr. Sneddon was a member of the New Leads Discovery group under innovator Fred Vinick. He then went to Genzyme with Fred to help establish Genzyme's small molecule drug discovery program. There he led the Assay Development and High Throughput Screening group and was a pioneer in implementing high-throughput functional cellular assays for primary drug screening (before such a thing was fashionable).